• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Resources for You


STN: 125444
Proper Name: Coagulation Factor IX (Recombinant), Fc Fusion Protein
Tradename: ALPROLIX
Manufacturer: Biogen Idec, Inc.

  • For adults and children with hemophilia B for: (1) Control and prevention of bleeding episodes, (2) Perioperative management, (3) Routine prophylaxis to prevent or reduce the frequency of bleeding episodes. ALPROLIX is not indicated for induction of immune tolerance in patients with Hemophilia B.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002